A short, 60 seconds read that summarises 4 handpicked articles that are worth reading about:
UK: Improving access to new treatments could extend lives and boost economy – Report
Germany: G-BA determines against application-accompanying data collection for Tabelecleucel
Sweden: TLV report on how ATMPs and precision medicines can be evaluated and paid for
An introduction to the Brazilian Market Access landscape and 5 things to consider prior to launch
How are countries in South-East Asia establishing HTA processes to progress towards Universal Health Coverage?
AIFA reform is a landmark change which propels Italy towards expedited drug approvals and improved a...
Government, NHS, and Pharma Industry Unveil Successor to Voluntary Scheme for Branded Medicines Pric...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.